Interneuron-specific dual-AAV SCN1A gene replacement corrects epileptic phenotypes in mouse models of Dravet syndrome
Science Translational Medicine · 19.03.2025 · 17 (790)
DOI: 10.1126/scitranslmed.adn5603 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Translational Medicine, erschienen am 19.03.2025. Verfasst von John K Mich und 17 weiteren Autor:innen. Beteiligte Einrichtung: Allen Institute for Brain Science, Seattle, WA 98109, USA. Hauptthemen laut MEDLINE: NAV1.1 Voltage-Gated Sodium Channel, Epilepsies, Myoclonic, Dependovirus, Interneurons. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: NHLBI NIH HHS, NIMH NIH HHS.
Abstract (Originalsprache)
Dravet syndrome (DS) is a severe developmental epileptic encephalopathy marked by treatment-resistant seizures, developmental delay, intellectual disability, motor deficits, and a 10 to 20% rate of premature death. Most patients with DS harbor loss-of-function mutations in one copy of SCN1A , which encodes the voltage-gated sodium channel (Na V )1.1 alpha subunit and has been associated with inhibitory neuron dysfunction. Here, we generated a split-intein form of SCN1A and used a dual-vector delivery approach to circumvent adeno-associated virus (AAV) packaging limitations. In addition, we applied previously developed enhancer technology to produce an interneuron-specific gene replacement therapy for DS, called DLX2.0- SCN1A . The split-intein SCN1A vectors produced full-length Na V 1.1 protein, and functional sodium channels were recorded in HEK293 cells in vitro. Administration of dual DLX2.0- SCN1A AAVs to wild-type mice produced full-length, reconstituted human protein by Western blot and telencephalic interneuron–specific and dose-dependent Na V 1.1 expression by immunohistochemistry. These vectors also conferred strong dose-dependent protection against postnatal mortality and seizures in Scn1a fl/+ ;Meox2-Cre and Scn1a +/R613X DS mouse models. Injection of single or dual DLX2.0- SCN1A AAVs into wild-type mice did not result in increased mortality, weight loss, or gliosis as measured by immunohistochemistry. In contrast, expression of SCN1A in all neurons driven by the human SYNAPSIN I promoter caused an adverse effect marked by increased mortality in the preweaning period, before disease onset. These findings demonstrate proof of concept that interneuron-specific AAV-mediated SCN1A gene replacement can rescue DS phenotypes in mouse models and suggest that it could be a therapeutic approach for patients with DS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Allen Institute for Brain Science, Seattle, WA 98109, USA.
- Seattle Children's Research Institute, Seattle, WA 98101, USA.
- University of Sao Paulo, Sao Paulo 05508-000, Brazil.
- Department of Neurological Surgery, University of Washington, Seattle, WA 98104, USA.
- Department of Neurobiology & Biophysics, University of Washington, Seattle, WA 98195, USA.
- Washington National Primate Research Center, University of Washington, Seattle, WA 98195, USA.
ORCID-Profile: John K Mich, Jiyun Ryu, Aguan D Wei, Bryan B Gore, Rong Guo, Angela M Bard, Refugio A Martinez, Emily M Luber, Robert J Christian, Luiz M Oliveira, Jonathan T Ting, Ed S Lein, Boaz P Levi, Franck K Kalume
Förderung
- NHLBI NIH HHS
- NIMH NIH HHS
Zitieren
APA
Mich, J. K., Ryu, J., Wei, A. D., Gore, B. B., Guo, R., Bard, A. M., Martinez, R. A., Luber, E. M., Liu, J., Bishaw, Y. M., Christian, R. J., Oliveira, L. M., Miranda, N., Ramirez, J. M., Ting, J. T., Lein, E. S., Levi, B. P., & Kalume, F. K. (2025). Interneuron-specific dual-AAV SCN1A gene replacement corrects epileptic phenotypes in mouse models of Dravet syndrome. Science Translational Medicine, 17(790). https://doi.org/10.1126/scitranslmed.adn5603
Vancouver
Mich JK, Ryu J, Wei AD, Gore BB, Guo R, Bard AM, et al. Interneuron-specific dual-AAV SCN1A gene replacement corrects epileptic phenotypes in mouse models of Dravet syndrome. Science Translational Medicine. 2025;17(790). doi:10.1126/scitranslmed.adn5603
BibTeX
@article{Mich2025,
author = {Mich, John K and Ryu, Jiyun and Wei, Aguan D and Gore, Bryan B and Guo, Rong and Bard, Angela M and Martinez, Refugio A and Luber, Emily M and Liu, Jiatai and Bishaw, Yemeserach M and Christian, Robert J and Oliveira, Luiz M and Miranda, Nicole and Ramirez, Jan-Marino and Ting, Jonathan T and Lein, Ed S and Levi, Boaz P and Kalume, Franck K},
title = {Interneuron-specific dual-AAV SCN1A gene replacement corrects epileptic phenotypes in mouse models of Dravet syndrome},
journal = {Science Translational Medicine},
year = {2025},
volume = {17},
number = {790},
doi = {10.1126/scitranslmed.adn5603}
}
EUVIMED